The European Union's drug watchdog said Wednesday that it has begun a review of an adapted version of Pfizer/BioNTech's anti-COVID jab that reportedly better protects against specific variants of the virus, including Omicron.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3